Clinical Trials on Respiratory Depression in Japan

Total 1193 results

Novartis Vaccines

Completed

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Influenza

Japan
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Influenza

Japan
Astellas Pharma Inc
Immunomic Therapeutics, Inc.

Completed

A Dose-finding Study of ASP4070

Rhinitis, Allergic, Seasonal

Japan
Pfizer

Active, not recruiting

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

COVID-19 | SARS-CoV-2

Japan
ModernaTX, Inc.

Completed

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

Coronavirus Disease (COVID-19)

Japan
National Hospital Organization Okayama Medical...
Bayer Yakuhin, Ltd.

Recruiting

THERAPY-HYBRID-BPA Trial

Hypertension, Pulmonary

Japan
GlaxoSmithKline

Completed

Phase I Study of GSK233705 in Healthy Japanese Male Subjects

Pulmonary Disease, Chronic Obstructive

Japan
Tomoshi Tsuchiya

Completed

A Feasibility Study of Oral Adjuvant Chemotherapy With S-1

Non-small Cell Lung Cancer

Japan
Kyoto University, Graduate School of Medicine

Completed

The Roles of Prostanoids in Patients With Sleep Apnea Syndrome

Sleep Apnea

Japan
Hamamatsu University

Completed

Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Japan
UMN Pharma Inc.

Completed

Study of ASP7374, Cell-culture-derived Influenza Vaccine

Influenza | Vaccine

Japan
Niigata University Medical & Dental Hospital

Completed

Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan

Pulmonary Alveolar Proteinosis, Autoimmune

Japan
Kyoto University, Graduate School of Medicine
Ministry of Health, Labour and Welfare, Japan

Unknown

Prognosis of Lung Transplant Candidates

Respiratory Failure | Lung Transplantation

Japan
GlaxoSmithKline

Recruiting

BOTOX® Drug Use Investigation (Spasmodic Dysphonia)

Dysphonia

Japan
Osaka University
Hospital Rebagliati

Completed

Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography

Critical Illness | ARDS

Japan
Pfizer

Recruiting

Safety and Efficacy of Lorbrena

Non-small Cell Lung Cancer

Japan
ModernaTX, Inc.

Completed

Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine

SARS-CoV-2

Japan
ModernaTX, Inc.

Completed

Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19

SARS-CoV-2

Japan
Takeda

Withdrawn

Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms

Coronavirus Disease (COVID-19)

Japan
Kyoto University, Graduate School of Medicine

Completed

Alterations in Postprandial Glucose and Lipid Metabolism in Patients With Obstructive Sleep Apnea

Obstructive Sleep Apnea

Japan
Nagasaki University

Completed

Cardiac Dysfunction in Obstructive Sleep Apnea Patients: Prevalence of and Effect of nCPAP

Sleep Apnea

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Japan
GlaxoSmithKline

Completed

Phase I Study of GW642444M in Healthy Japanese Male Subjects

Pulmonary Disease, Chronic Obstructive

Japan
Tokyo University
Shionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaborators

Unknown

Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer

Non-small- Cell Lung Cancer

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Japan
AstraZeneca

Completed

Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)

Carcinoma, Non-Small-Cell Lung

Japan
AstraZeneca

Completed

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

Asthma

Japan
UMN Pharma Inc.

Completed

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Influenza

Japan
GlaxoSmithKline

Completed

A Study of GSK573719 in Healthy Japanese Male Subjects

Pulmonary Disease, Chronic Obstructive

Japan
Shiga University
University of Chicago; Shionogi; Tokyo University; Showa University; Fukushima Medical... and other collaborators

Unknown

Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Japan
Kyowa Kirin Co., Ltd.

Terminated

A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib (ATTENTION)

Non-small-cell Lung Cancer

Japan
Eli Lilly and Company

Completed

A Study of LY2875358 in Japanese Participants With Advanced Cancer

Lymphoma | Carcinoma, Non-Small-Cell Lung | Solid Tumors

Japan
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Japan
AstraZeneca

Terminated

Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients

Carcinoma, Non-Small-Cell Lung

Japan
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

Japan
Sumitomo Pharma Co., Ltd.

Completed

DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season

Allergic Rhinitis | Healthy Volunteer

Japan
UMN Pharma Inc.

Completed

A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers

Healthy

Japan
GlaxoSmithKline

Completed

ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Japan
Wakayama Medical University
Merck Sharp & Dohme LLC

Unknown

Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer

Small Cell Lung Cancer Extensive Stage

Japan
Gifu Prefecture Medical Association
Sanofi Pasteur S.A.

Completed

Seroepidemiological Study of Pertussis and Other Infectious Diseases

Pertussis Infection

Japan
Takeda

Recruiting

Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

Japan
Kyoto University, Graduate School of Medicine

Completed

Treatment Adherence and Outcomes in Three Modalities of Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea

Obstructive Sleep Apnea

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of ARQ 197 in Combination With Erlotinib

Advanced/Recurrent Non-small-cell Lung Cancer

Japan
National Hospital Organization Minami Kyoto Hospital

Completed

Visual and Auditory Breathing-swallowing Coordinated Training

Breathing-Swallowing Coordination | Dysphagia Rehabilitation

Japan
GlaxoSmithKline

Completed

Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics

Rhinitis

Japan
GlaxoSmithKline

Completed

Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects

Cardiovascular Disease

Japan
Yuka Kadomatsu

Recruiting

Most Preventable Surgical Option to Reduce Primary Spontaneous Pneumothorax Patients' Postoperative Recurrence: A Prospective Cohort Study

Recurrence | Surgery | Spontaneous Pneumothorax

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects

Covid19

Japan
Kitasato University

Active, not recruiting

Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

Covid19

Japan
GlaxoSmithKline

Completed

Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis

Sinusitis, Acute

Japan

3

Subscribe